Scoring systems for predicting genotype-matched clinical trial enrollment rates after CGP testing

Scoring systems for predicting genotype-matched clinical trial enrollment rates after CGP testing - SPECTRA

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1030240477

Enrollment

150

Registered

2024-11-11

Start date

2024-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Solid tumors Genotype-matched trial

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Physicians who performed cancer gene panel testing 2. Physicians who referred patients to National Cancer Center Hospital for clinical trials matched to genetic alterations

Exclusion criteria

Exclusion criteria: Physicians deemed inappropriate by the Principal Investigator

Design outcomes

Primary

Measure	Time frame
Primary endpoint: Comparison of AUC between the scoring system prediction and referring physicians' prediction	—

Secondary

Measure	Time frame
Secondary endpoint: Comparison of AUC based on referring physicians' experience with CGP testing	—

Contacts

Public ContactYuji Uehara

National Cancer Center Hospital, Department of Experimental Therapeutics

yuueha2@ncc.go.jp+81-3-3542-2511

Outcome results